Francesca Esposito | Biomedical Sciences | Excellence in Research

Posted on by The Scientist

Assoc. Prof. Dr. Francesca Esposito | Biomedical Sciences | Excellence in Research

Università di Cagliari | Italy

Dr. Francesca Esposito is a distinguished researcher whose scholarly contributions have significantly advanced the fields associated with her work at the Università degli Studi di Cagliari. Her research excellence is reflected in a strong global academic footprint, supported by 2,349 citations, 92 peer-reviewed documents, and an h-index of 30, underscoring her consistent influence, productivity, and high-impact scholarship. Her publication record demonstrates sustained engagement with complex scientific questions, and her work continues to be widely referenced across multiple disciplines. Throughout her career, Dr. Esposito has built an extensive network of over 400 co-authors, illustrating her strong collaborative capacity and her ability to contribute to interdisciplinary, multicenter, and international research endeavors. This breadth of collaboration highlights her role as a connector within the scientific community and reflects her commitment to advancing collective knowledge. Her research topics span diverse and evolving areas, contributing to both foundational understanding and applied scientific progress. Dr. Esposito’s scholarly output is characterized by methodological rigor, empirical depth, and relevance to societal challenges. Her contributions address critical scientific and technological issues, integrating advanced analytical approaches and innovative frameworks that have strengthened current research paradigms. Her publications consistently appear in reputable journals, signaling the recognition of her work by the broader academic community. Beyond academic metrics, Dr. Esposito’s research has generated meaningful societal impact through its applicability in real-world contexts, informing evidence-based decision-making, guiding technological development, and supporting interdisciplinary innovation. Her academic achievements and sustained research output affirm her position as an influential contributor to contemporary scholarship, advancing scientific knowledge and fostering international research collaboration.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Fulle, M., Marzari, F., Della Corte, V., Fornasier, S., Sierks, H., Rotundi, A., … Esposito, F. (2016). Evolution of the dust size distribution of comet 67P/Churyumov–Gerasimenko from 2.2 AU to perihelion. The Astrophysical Journal, 821(1), 19. Cited by: 225

  2. Formisano, V., Angrilli, F., Arnold, G., Atreya, S., Bianchini, G., Biondi, D., … Esposito, F. (2005). The planetary Fourier spectrometer (PFS) onboard the European Mars Express mission. Planetary and Space Science, 53(10), 963–974. Cited by: 208

  3. Fulle, M., Della Corte, V., Rotundi, A., Weissman, P., Juhasz, A., Szego, K., … Esposito, F. (2015). Density and charge of pristine fluffy particles from comet 67P/Churyumov–Gerasimenko. The Astrophysical Journal Letters, 802(1), L12. Cited by: 189

  4. Rotundi, A., Sierks, H., Della Corte, V., Fulle, M., Gutierrez, P. J., Lara, L., … Esposito, F. (2015). Dust measurements in the coma of comet 67P/Churyumov–Gerasimenko inbound to the Sun. Science, 347(6220), aaa3905. Cited by: 179

  5. Esposito, F., Molinaro, R., Popa, C. I., Molfese, C., Cozzolino, F., Marty, L., … Määttänen, A. (2016). The role of the atmospheric electric field in the dust‐lifting process. Geophysical Research Letters, 43(10), 5501–5508. Cited by: 114

Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Posted on by The Scientist

Dr. Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Research scientist |  School of Tropical Medicine, Hainan Medical University, Haikou, Hainan | China

Dr. Songlin Zhou is a highly productive and influential researcher whose work spans biomedical sciences, network pharmacology, molecular modeling, and bio-nanotechnology. His scholarly contributions demonstrate a sustained commitment to addressing complex medical and biological challenges through integrative, technology-driven approaches. With 576 citations, 37 peer-reviewed publications, and an h-index of 13, Dr. Zhou has established a meaningful presence in the global scientific community. His recent research includes advanced network pharmacology and molecular simulation studies uncovering the mechanisms of therapeutic compounds such as halociline in gastric cancer, as well as pioneering analyses on gut microbial metabolites that elucidate dual-axis pathogenesis in Crohn’s disease. His open-access work on green biosynthesized silver nanoparticles showcases his interdisciplinary strength, contributing to the development of multifunctional hemostatic agents that combine antibacterial, anti-inflammatory, and wound-healing properties. Dr. Zhou’s portfolio reflects wide-ranging international collaboration, with co-authorship across 60 researchers, demonstrating his active engagement in cross-institutional and cross-disciplinary scientific networks. His research not only advances fundamental understanding in disease mechanisms and therapeutic target identification but also supports translational innovation in biomaterials and clinical applications. Through this integrated body of work, Dr. Zhou continues to generate societal impact by contributing to emerging biomedical solutions, strengthening evidence-based therapeutic strategies, and fostering global scientific cooperation.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Chen, S., Li, Y., Liu, J., Wu, J., Zhao, H., Cao, R., & Zhou, S. (2025). Gut microbial metabolite crosstalk in Crohn’s disease: Network pharmacology unveils dual-axis pathogenesis and therapeutic targets. BioFactors.

  2. Li, Y., Tan, Y., Zhao, H., Chen, S., Nilghaz, A., Cao, R., & Zhou, S. (2025). Green biosynthetic silver nanoparticles from Ageratum conyzoides as multifunctional hemostatic agents: Combining hemostasis, antibacterial, and anti-inflammatory properties for effective wound healing. Materials Today Bio, 101468.

  3. Zha, X., Li, Y., Zhao, H., Tan, Y., & Zhou, S. (2024). Pyrrolidine, piperazine, and diazinane alkaloids from the marine bacterium strain Vibrio ruber ZXR-93. Molecules, 29(18), 4446.

  4. Zhang, K., Li, X., Yan, C., Shi, R., Fang, Z., Zhou, S., Cao, R., & Tian, J. (2024). All-wood-based ionic power generator with dual functions for alkaline wastewater reuse and energy harvesting. ACS Nano.

  5. Xu, Z., Zha, X., Ji, R., Zhao, H., & Zhou, S. (2023). Green biosynthesis of silver nanoparticles using aqueous extracts of Ageratum conyzoides and their anti-inflammatory effects. ACS Applied Materials & Interfaces.

Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Dr. Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Professor | Mahatma Gandhi Medical College & Hospital | India

Dr. E. Rajni Sabharwal, MD in Microbiology, is a leading researcher in clinical microbiology, antimicrobial resistance (AMR), and infection control. Her research focuses on emerging multidrug-resistant and extensively drug-resistant organisms, epidemiology of hospital-acquired infections, and antimicrobial susceptibility patterns in critical clinical settings, including urinary tract and bloodstream infections. She actively contributes to national multicentric studies on AMR surveillance and the implementation of antimicrobial and diagnostic stewardship programs, integrating One Health approaches. Dr. Sabharwal’s work encompasses molecular characterization of pathogens, synergy testing of novel antibiotic combinations, biofilm studies, and evaluation of rapid diagnostic tools to optimize patient management. Her publications address Gram-negative resistance, carbapenem-resistant Enterobacterales, Stenotrophomonas and MRSA infections, fungal pathogens, and empirical management strategies in tertiary care hospitals. She also investigates the role of immunotherapeutic interventions, such as SPAG9-primed dendritic cell-based vaccines, in gallbladder cancer. With expertise in epidemiological research, laboratory diagnostics, and clinical trial design, she has advanced knowledge on antimicrobial stewardship and resistance mitigation. Through workshops, symposia, and mentorship, Dr. Sabharwal promotes evidence-based practices, bridging clinical microbiology with public health strategies to combat AMR and improve patient outcomes, establishing her as a prominent contributor to infectious disease research and translational microbiology. (210 citations by ; 36 Documents; h-index: 8).

Profiles: Google scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Sabharwal, E. R. (2012). Antibiotic susceptibility patterns of uropathogens in obstetric patients. North American Journal of Medical Sciences, 4(7), 316. Citations: 106

  2. Sabharwal, E. R., & Sharma, R. (2015). Fosfomycin: An alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance. Journal of Clinical and Diagnostic Research, 9(12), DC06–DC09. Citations: 48

  3. Sabharwal, E. R., & Sharma, R. (2015). Estimation of microbial air contamination by settle plate method: Are we within acceptable limit? Scholars Academic Journal of Biosciences, 3(8), 703–707. Citations: 15

  4. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian Journal of Pathology and Microbiology, 53(2), 387–388. Citations: 14

  5. Jain, M., Sabharwal, E. R., & Srivastava, D. (2016). Practices of health care personnel regarding occupational exposure. Journal of Clinical and Diagnostic Research, 10(11), DC14–DC17. Citations: 12